Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
More than a decade later, in 2005, exenatide (a synthetic version of exendin-4) was approved as the first anti-diabetes medication in the GLP-1 receptor agonist class by the U.S
doi: 10.1111/dom.14244, 12 BrierleyD
Presented for research literature review only Arafa HM et al
For miscarriage risk, women with obesity or diabetes face a 25-30% baseline risk compared to 10-15% in the general population
10.1016/j.bbadis.2014.02.009 327 TangB
US$ 21.24
US$ 25.76
US$ 28.39
US$ 29.33
US$ 28.90
